Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $22.0 million.

  • Lifecore Biomedical's Accumulated Expenses fell 2.57% to $22.0 million in Q2 2025 from the same period last year, while for May 2025 it was $22.0 million, marking a year-over-year decrease of 2.57%. This contributed to the annual value of $22.0 million for FY2025, which is 2.57% down from last year.
  • Lifecore Biomedical's Accumulated Expenses amounted to $22.0 million in Q2 2025, which was up 11.21% from $19.7 million recorded in Q1 2025.
  • Lifecore Biomedical's Accumulated Expenses' 5-year high stood at $22.5 million during Q2 2024, with a 5-year trough of $3.3 million in Q4 2021.
  • For the 3-year period, Lifecore Biomedical's Accumulated Expenses averaged around $9.7 million, with its median value being $5.1 million (2024).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 53.64% in 2023, then soared by 443.74% in 2024.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Accumulated Expenses stood at $3.3 million in 2021, then increased by 26.04% to $4.1 million in 2022, then declined by 18.27% to $3.4 million in 2023, then spiked by 38.07% to $4.6 million in 2024, then fell by 2.57% to $22.0 million in 2025.
  • Its Accumulated Expenses stands at $22.0 million for Q2 2025, versus $19.7 million for Q1 2025 and $4.6 million for Q4 2024.